يعرض 1 - 10 نتائج من 66 نتيجة بحث عن '"Heinrich M. C."', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
    دورية أكاديمية
    A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor

    المؤلفون: Pantaleo M. A., Heinrich M. C., Italiano A., Valverde C., Schoffski P., Grignani G., Reyners A. K. L., Bauer S., Reichardt P., Stark D., Berhanu G., Brandt U., Stefanelli T., Gelderblom H.

    المساهمون: Pantaleo M.A., Heinrich M.C., Italiano A., Valverde C., Schoffski P., Grignani G., Reyners A.K.L., Bauer S., Reichardt P., Stark D., Berhanu G., Brandt U., Stefanelli T., Gelderblom H.

    مصطلحات موضوعية: Alpelisib, Gastrointestinal stromal tumor, GIST, Imatinib, Regorafenib, Sunitinib

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35524239; info:eu-repo/semantics/altIdentifier/wos/WOS:000791786100010; volume:22; issue:1; firstpage:1; lastpage:8; numberofpages:8; journal:BMC CANCER; https://hdl.handle.net/11585/959931Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85129579688; https://pubmed.ncbi.nlm.nih.gov/35524239Test/

    الإتاحة: https://doi.org/10.1186/s12885-022-09610-4Test
    https://hdl.handle.net/11585/959931Test
    https://pubmed.ncbi.nlm.nih.gov/35524239Test/

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY DATA FROM A PHASE I TRIAL

    المؤلفون: Hughes, T., Cortes, J. E., Réa, D., Mauro, M. J., Hochhaus, A., Kim, D.-W., Sasaki, K., Lang, F., Heinrich, M. C., Breccia, M., Deininger, M., Goh, Y.-T., Janssen, J. J., Talpaz, M., Gómez García de Soria, V., le Coutre, P., Kapoor, S., Cacciatore, S., Polydoros, F., Agrawal, N., Mahon, F.-X.

    المصدر: HemaSphere ; volume 6, page 599-600 ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000845700.84142.c0Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Avapritinib versus regorafenib in locally advanced unresectable or metastatic GI stromal tumor: A randomized, open-label phase III study

    المؤلفون: Kang Y. -K., George S., Jones R. L., Rutkowski P., Shen L., Mir O., Patel S., Zhou Y., von Mehren M., Hohenberger P., Villalobos V., Brahmi M., Tap W. D., Trent J., Pantaleo M. A., Schoffski P., He K., Hew P., Newberry K., Roche M., Heinrich M. C., Bauer S.

    المساهمون: Kang Y.-K., George S., Jones R.L., Rutkowski P., Shen L., Mir O., Patel S., Zhou Y., von Mehren M., Hohenberger P., Villalobos V., Brahmi M., Tap W.D., Trent J., Pantaleo M.A., Schoffski P., He K., Hew P., Newberry K., Roche M., Heinrich M.C., Bauer S.

    مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agent, Asia, Australia, Disease Progression, Drug Administration Schedule, Europe, Female, Gastrointestinal Neoplasm, Gastrointestinal Stromal Tumor, Human, Male, Middle Aged, Mutation, North America, Phenylurea Compound, Progression-Free Survival, Protein Kinase Inhibitor, Proto-Oncogene Proteins c-kit, Pyrazole, Pyridine, Pyrrole, Receptor, Platelet-Derived Growth Factor alpha, Time Factor, Triazines

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34343033; info:eu-repo/semantics/altIdentifier/wos/WOS:000708641200006; volume:39; issue:28; firstpage:3128; lastpage:3139; numberofpages:12; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11585/864328Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117739966

    الإتاحة: https://doi.org/10.1200/JCO.21.00217Test
    https://hdl.handle.net/11585/864328Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

    المؤلفون: Serrano C., Bauer S., Gómez-Peregrina D., Kang Y. K., Jones R. L., Rutkowski P., Mir O., Heinrich M. C., Tap W. D., Newberry K., Grassian A., Shi H., Bialick S., Schöffski P., Pantaleo M. A., von Mehren M., Trent J. C., George S.

    المساهمون: Serrano C., Bauer S., Gómez-Peregrina D., Kang Y.K., Jones R.L., Rutkowski P., Mir O., Heinrich M.C., Tap W.D., Newberry K., Grassian A., Shi H., Bialick S., Schöffski P., Pantaleo M.A., von Mehren M., Trent J.C., George S.

    مصطلحات موضوعية: GIST, KIT, PDGFRA, avapritinib, ctDNA, regorafenib

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37105265; info:eu-repo/semantics/altIdentifier/wos/WOS:001032844900001; volume:34; issue:7; firstpage:615; lastpage:625; numberofpages:11; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11585/959942Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85160057166

    الإتاحة: https://doi.org/10.1016/j.annonc.2023.04.006Test
    https://hdl.handle.net/11585/959942Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    INTRIGUE : eine randomisierte, offene Phase-3-Studie zur Bewertung der Wirksamkeit und Sicherheit von Ripretinib im Vergleich zu Sunitinib bei Patienten mit fortgeschrittenem gastrointestinalem Stromatumor, die zuvor mit Imatinib behandelt wurden

    المؤلفون: Bauer, Sebastian, Jones, R. L., Gelderblom, H., George, S., Schöffski, P., von Mehren, M., Zalcberg, J., Kang, Y.-K., Razak, A. A., Trent, J., Attia, S., Le Cesne, A., Su, Y., Meade, J., Wang, T., Sherman, M. L., Ruiz-Soto, R., Blay, J.-Y., Heinrich, M. C.

    مصطلحات موضوعية: Medizin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=unidue___bib::6a2c9dfb40ccd31075a07b296aa1f215Test


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

    المؤلفون: Hughes, T. P., Mauro, M. J., Cortes, J. E., Minami, H., Rea, D., DeAngelo, D. J., Breccia, M., Goh, Y. -T., Talpaz, M., Hochhaus, A., le Coutre, P., Ottmann, O., Heinrich, M. C., Steegmann, J. L., Deininger, M. W. N., Janssen, J. J. W. M., Mahon, F. -X., Minami, Y., Yeung, D., Ross, D. M., Tallman, M. S., Park, J. H., Druker, B. J., Hynds, D., Duan, Y., Meille, C., Hourcade-Potelleret, F., Vanasse, K. G., Lang, F., Kim, D. -W.

    المساهمون: Hughes, T. P., Mauro, M. J., Cortes, J. E., Minami, H., Rea, D., Deangelo, D. J., Breccia, M., Goh, Y. -T., Talpaz, M., Hochhaus, A., le Coutre, P., Ottmann, O., Heinrich, M. C., Steegmann, J. L., Deininger, M. W. N., Janssen, J. J. W. M., Mahon, F. -X., Minami, Y., Yeung, D., Ross, D. M., Tallman, M. S., Park, J. H., Druker, B. J., Hynds, D., Duan, Y., Meille, C., Hourcade-Potelleret, F., Vanasse, K. G., Lang, F., Kim, D. -W.

    مصطلحات موضوعية: DIAGNOSED CHRONIC-PHASE, DOMAIN MUTATIONS, CLINICAL RESISTANCE, FOLLOW-UP, IMATINIB, CML, RECOMMENDATIONS, DASATINIB, SURVIVAL, IMPACT

    العلاقة: volume:381; issue:24; firstpage:2315; lastpage:2326; numberofpages:12; journal:THE NEW ENGLAND JOURNAL OF MEDICINE; https://hdl.handle.net/11573/1690548Test

    الإتاحة: https://doi.org/10.1056/NEJMoa1902328Test
    https://hdl.handle.net/11573/1690548Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Long-term efficacy, tolerability, and overall survival in patients with unresectable or metastatic platelet-derived growth factor receptor A (PDGFRA) D842V-mutant gastrointestinal stromal tumors (GIST) treated with avapritinib : NAVIGATOR phase 1 trial update

    المؤلفون: Bauer, Sebastian, Serrano, C., Mehren, M. von, George, S., Heinrich, M. C., Kang, Y.-K., Schöffski, P., Cassier, P. A., Mir, O., Eskens, F., Rutkowski, P., Tap, W., Roche, M., Jones, R. L.

    مصطلحات موضوعية: Medizin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=unidue___bib::102ac31bed3c804f5f13ae4716af269aTest


    أضف إلى المفضلة
  8. 8
    Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib : NAVIGATOR phase I trial update

    المؤلفون: Kang, Y.-K., Jones, R. L., von Mehren, M., Serrano, C., George, S., Heinrich, M. C., Schöffski, P., Mir, O., Cassier, P. A., Eskens, F., Rutkowski, P., Tap, W. D., Chawla, S. P., Shi, H., Roche, M., Bauer, Sebastian

    مصطلحات موضوعية: Medizin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=unidue___bib::4a1040f413cdc1be375f79e8fcae9ae7Test


    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia

    المؤلفون: Bains, T, Heinrich, M C, Loriaux, M M, Beadling, C, Nelson, D, Warrick, A, Neff, T L, Tyner, J W, Dunlap, J, Corless, C L, Fan, G

    المصدر: Leukemia ; volume 26, issue 9, page 2144-2146 ; ISSN 0887-6924 1476-5551

    مصطلحات موضوعية: Oncology, Cancer Research, Hematology

    الإتاحة: https://doi.org/10.1038/leu.2012.74Test
    https://www.nature.com/articles/leu201274.pdfTest
    https://www.nature.com/articles/leu201274Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    SDHA Loss-of-Function Mutations in KIT-PDGFRA Wild-Type Gastrointestinal Stromal Tumors Identified by Massively Parallel Sequencing

    المؤلفون: Pantaleo, M. A., Astolfi, A., Indio, V., Moore, R., Thiessen, N., Heinrich, M. C., Gnocchi, C., Santini, D., Catena, F., Formica, S., Martelli, P. L., Casadio, R., Pession, A., Biasco, G.

    المصدر: JNCI Journal of the National Cancer Institute ; volume 103, issue 12, page 983-987 ; ISSN 0027-8874 1460-2105

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1093/jnci/djr130Test
    http://academic.oup.com/jnci/article-pdf/103/12/983/17310994/djr130.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث